Strategic question
Which personal-health ventures are the optimal fit for our two priority therapeutic areas across the major global ecosystems?
How Galen Growth helped
From market signal to decision-ready evidence
Using HealthTech Alpha’s Alpha Score and proprietary market signals, we evaluated 259 personal-health ventures across three regions and applied strategic, clinical and commercial filters to arrive at a final selection of 10.
Outcomes
Cut through volume to isolate the ventures with the strongest strategic and clinical fit against enterprise criteria.
Decision enabled: Enabled BD and franchise teams to enter partnership conversations with a defensible top-10.
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Selecting Cardiac Remote Monitoring Partners for Personalised Patient Care
Which cardiac remote monitoring ventures are mature enough to support personalised patient care across our priority markets?
Shortlisting ventures for cardio remote monitoring
Our client, one of the major global medical device companies, wanted to identify digital health solutions across five markets: USA, France, Germany, UK and Italy. Their specific focus was to enhance patient care in life changing medical events via personalised support across their therapeutic priorities
Shortlisting personal health ventures in key therapeutic areas
A global leading medical device company sought to understand the personal health Digital Health landscape for two priority therapeutic areas in key global ecosystems to identify and evaluate relevant ventures